Back to Agendas
Asia Town Hall: Asia as a Drug R&D Center in the World
Session Chair(s)
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor, Sunflare, Japan
This session will address the current status of the regulatory environment as well as recent achievements and challenges of drug development in Asian countries.
Learning Objective : Recognize the current status and challenges of Asian regulators regarding international collaboration; Describe the importance and possibility of Asian countries as multiregional clinical trial centers; Discuss various Asian regulatory authorities regulatory environments.
Speaker(s)
Industry Perspective: Multiregional Clinical Trials Updates in Japan and Regulatory Convergence Among Asian Countries
Chitose Nishida
Department Manager of Regulatory Excellence , GlaxoSmithKline K.K., Japan
Updates of MRCT in Japan
Yuki Ando, PhD
Principal Senior Scientist for Biostatistics, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Panelist
Silke Vogel, PhD
Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean, Duke NUS , Singapore
Have an account?
Ways to register
Registration override should work.